Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients

Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict... Ann Hematol (2017) 96:1587–1588 DOI 10.1007/s00277-017-3052-4 LETTER TO THE EDITOR Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients 1,2 2 2 Hiroshi Ureshino & Kazuharu Kamachi & Masaharu Miyahara Received: 23 May 2017 /Accepted: 15 June 2017 /Published online: 27 June 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, genase and soluble interleukin-2 receptor did not decrease, Human T-cell lymphotropic virus type I (HTLV-I) specific indicating that ATL was refractory. Subsequently, cytotoxic T lymphocytes (CTLs) exhibit cytotoxicity against mogamulizumab and half-doses of cyclophosphamide, doxo- HTLV-I infected T-cells, resulting in the regulation of HTLV-I rubicin, vincristine, and prednisolone (CHOP) were adminis- tered. After two courses of chemotherapy, the patient achieved proviral load. CTLs are rarely seen in adult T-cell leukemia/ lymphoma (ATL) patients, but are strongly activated in some and remained in CR >42 months. HTLV-I specific CTLs were ATL patients who remain in complete remission (CR) after detected (0.38%) in her PB at 14 months after allogenic stem cell transplantation (allo-SCT) [1]; moreover, mogamulizumab administration (Fig. 1). CTLs also regulate ATL disease progression [2]. Tax peptide- Our patient achieved extremely long-term remission after pulsed dendritic cell vaccination can strongly http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Hematology Springer Journals

Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients

Loading next page...
 
/lp/springer_journal/detection-of-human-t-cell-lymphotropic-virus-type-i-specific-cytotoxic-cL5365pyij
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Hematology; Oncology
ISSN
0939-5555
eISSN
1432-0584
D.O.I.
10.1007/s00277-017-3052-4
Publisher site
See Article on Publisher Site

Abstract

Ann Hematol (2017) 96:1587–1588 DOI 10.1007/s00277-017-3052-4 LETTER TO THE EDITOR Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients 1,2 2 2 Hiroshi Ureshino & Kazuharu Kamachi & Masaharu Miyahara Received: 23 May 2017 /Accepted: 15 June 2017 /Published online: 27 June 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, genase and soluble interleukin-2 receptor did not decrease, Human T-cell lymphotropic virus type I (HTLV-I) specific indicating that ATL was refractory. Subsequently, cytotoxic T lymphocytes (CTLs) exhibit cytotoxicity against mogamulizumab and half-doses of cyclophosphamide, doxo- HTLV-I infected T-cells, resulting in the regulation of HTLV-I rubicin, vincristine, and prednisolone (CHOP) were adminis- tered. After two courses of chemotherapy, the patient achieved proviral load. CTLs are rarely seen in adult T-cell leukemia/ lymphoma (ATL) patients, but are strongly activated in some and remained in CR >42 months. HTLV-I specific CTLs were ATL patients who remain in complete remission (CR) after detected (0.38%) in her PB at 14 months after allogenic stem cell transplantation (allo-SCT) [1]; moreover, mogamulizumab administration (Fig. 1). CTLs also regulate ATL disease progression [2]. Tax peptide- Our patient achieved extremely long-term remission after pulsed dendritic cell vaccination can strongly

Journal

Annals of HematologySpringer Journals

Published: Jun 27, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off